Ryan Gamble, MD
Dermatology · Aurora, CONPI 1881988913
Payments from drug & device makers
Across 534 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$1K
- Sanofi$916
- Novartis$763
- E.r. Squibb & Sons, L.L.C.$642
- Regeneron Healthcare Solutions, Inc.$528
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 141 | $2,589 |
| Johnson & Johnson | 52 | $1,134 |
| Sanofi | 33 | $916 |
| Novartis | 36 | $763 |
| E.r. Squibb & Sons, L.L.C. | 35 | $642 |
| Regeneron Healthcare Solutions, Inc. | 20 | $528 |
| Sun Pharmaceutical Industries Inc. | 29 | $505 |
| Pfizer | 21 | $416 |
| Lilly USA, LLC | 14 | $401 |
| LEO Pharma Inc. | 24 | $355 |
| Amgen | 17 | $330 |
| Incyte Corporation | 20 | $308 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 14 | $243 |
| Galderma Laboratories, L.p. | 16 | $232 |
| Dermavant Sciences, Inc. | 10 | $160 |
| Arcutis Biotherapeutics, Inc. | 7 | $140 |
| Almirall LLC | 6 | $102 |
| Organon | 13 | $101 |
| Strata Skin Sciences, Inc. | 1 | $77 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $56 |
| Genentech USA, Inc. | 3 | $51 |
| UCB, Inc. | 2 | $45 |
| EPI Health, LLC | 2 | $38 |
| VYNE Pharmaceuticals Inc. | 2 | $34 |
| Mayne Pharma Commercial LLC | 2 | $28 |
| Bristol Myers Squibb | 2 | $27 |
| Verrica Pharmaceuticals Inc. | 2 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Merck | 2 | $22 |
| DUSA Pharmaceuticals, Inc. | 1 | $20 |
| Dermira, Inc. | 1 | $16 |
| Aclaris Therapeutics, Inc. | 1 | $14 |
How this compares
$10,372 in reported general payments places this provider in the 85th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Aurora
- Stanca BirleaAurora$1.9M
- Theodore AlkousakisAurora$880K
- Cory DunnickAurora$366K
- David NorrisAurora$156K
- Dawnielle EndlyAurora$105K
- Elizabeth WallaceAurora$97K
- Torunn SivesindAurora$93K
- Carla Torres-ZegarraAurora$62K
- Robert DellavalleAurora$46K
- Emily GorellAurora$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.